ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.97806
0.20%
Brent Oil
83.61
0.08%
Bitcoin
59,144.48
1.56%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX
  6. Theratechnologies Inc (TH)

  7. Theratechnologies Inc (TH) Noticias

TH Theratechnologies Inc

1.77
-0.02 (-1.12%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Theratechnologies Inc TH Toronto Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.02 -1.12% 1.77 15:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.80 1.76 1.80 1.77 1.79
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
15/4/202415:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/4/202406:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/4/202406:30GLOBETheratechnologies Reports Financial Results and Provides..
08/4/202415:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
05/4/202410:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/4/202406:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/3/202406:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/3/202408:36GLOBETheratechnologies Announces Update on its Preclinical..
21/3/202419:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/3/202406:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
29/2/202415:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/2/202406:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/2/202406:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/2/202406:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/2/202406:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
06/2/202406:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
24/1/202409:47DJNTheratechnologies Shares Sink at Open After FDA Rejects..
24/1/202407:52DJNTheratechnologies Shares Slide Premarket as FDA Turns Away..
24/1/202406:49DJNTheratechnologies: FDA Rejects Newer Egrifta Formulation
24/1/202406:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
23/1/202409:16DJNTheratechnologies Shares Fall as FDA Continues to Review..
23/1/202406:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
02/1/202408:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/1/202406:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
21/12/202315:12PRNCATheratechnologies annonce le renouvellement de son..
21/12/202315:09PRNUSTheratechnologies Announces Renewal of Shelf Prospectus and..
13/12/202306:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
24/11/202306:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
31/10/202311:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
26/10/202307:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
25/10/202315:13GLOBETheratechnologies Announces Proposed Public Offering of..
24/10/202306:00GLOBETheratechnologies Announces Operational Update
19/10/202306:30GLOBETheratechnologies’ Ibalizumab Demonstrates..
16/10/202306:30GLOBETheratechnologies Announces Finalization of Amendments to..
13/10/202306:30GLOBETheratechnologies Presents Data at ID Week Showing..
13/10/202306:00GLOBETheratechnologies Announces Results from Trogarzo®..
12/10/202306:30GLOBETheratechnologies Announces Dosing of First Patient in..
04/10/202306:30GLOBETheratechnologies Receives January 2024 PDUFA Goal Date for..
26/9/202306:30GLOBETheratechnologies Reports Financial Results for the Third..
25/9/202306:30GLOBETheratechnologies Announces Agreement in Principle with..
25/9/202306:00GLOBETheratechnologies Submits Tesamorelin F8 Formulation sBLA..
20/9/202306:00GLOBETheratechnologies to Present at the Cantor Fitzgerald Global..
18/9/202315:15GLOBETheratechnologies to Announce Third Quarter 2023 Financial..
07/9/202312:57GLOBETheratechnologies to Present at the H.C. Wainwright 25th..
05/9/202306:00GLOBETheratechnologies Announces Certain Preliminary Q3 2023..
30/8/202309:34GLOBETheratechnologies Announces All U.S. Oncology Clinical Sites..
21/8/202314:24PRNUSToronto Stock Exchange, Theratechnologies Inc., View From..
31/7/202308:00APSBiopharma Firm Completes Reverse Stock Split
31/7/202306:00GLOBETheratechnologies Completes 1-for-4 Reverse Stock Split

Su Consulta Reciente

TSX
TH
Theratechnologies
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados